Method For Reducing Effect Of Hematocrit On Measurement Of An Analyte In Whole Blood, And Test Kit And Test Article Useful In The Method

Patent No. EP1447665 (titled "Method For Reducing Effect Of Hematocrit On Measurement Of An Analyte In Whole Blood, And Test Kit And Test Article Useful In The Method") was filed by Ascensia Diabetes Care on Jan 31, 2004. The application was issued on Jun 29, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TERUMOMar 10, 2017MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1447665

ASCENSIA DIABETES CARE
Application Number
EP04002141A
Filing Date
Jan 31, 2004
Status
Revoked
Apr 6, 2018
Publication Date
Jun 29, 2016